Does inositol work for PCOS?

Does inositol work for PCOS?

The best current evidence, a 2026 review of thirteen meta-analyses, shows inositol modestly improves ovulation and hormone markers in women with PCOS compared with placebo, though almost none of that evidence is rated high quality. It does not beat metformin overall, and the '40 to 70 percent' fertility claims sold online trace to no named trial.

What inositol actually is, and why it ended up on every hormone-balance shelf

Inositol is a sugar alcohol the body makes and also gets from foods like citrus and legumes. Supplement brands sell two forms, myo-inositol and D-chiro-inositol, usually blended at a 40:1 ratio meant to mirror what the body carries naturally. Because PCOS involves insulin resistance, and inositol affects how cells respond to insulin, it moved from a niche fertility-clinic supplement into general wellness marketing for hormone balance, often aimed at people who have never been diagnosed with PCOS at all. That broader framing is where the evidence gets thinnest.

The best evidence we have: a 2026 review of 13 meta-analyses

In February 2026, researchers led by Hongqiu Zhu published an umbrella review in Frontiers in Endocrinology, pooling 13 meta-analyses of randomized trials on inositol for PCOS. Inositol lowered luteinizing hormone and free testosterone, raised SHBG, and improved insulin resistance (HOMA-IR fell by 1.14 on average) compared with placebo or folic acid alone. Ovulation rates were more than double (RR 2.75), and overall pregnancy rates were higher (RR 1.29). That sounds decisive until you look at the quality grading underneath it: of 85 separate evidence ratings in the review, none were graded high quality, and 41% were rated very low under GRADE criteria. The authors wrote that inositol "improves core PCOS manifestations" and called it "a promising therapy," but added that outcomes based on low-quality evidence "require cautious interpretation and should not solely guide clinical decisions."

Where the marketing gets ahead of the data

Search for inositol and PCOS and the top results are telehealth and supplement company blogs citing ovulation improvements of 40 to 70%, pregnancy rates of 40 to 65% in previously infertile women, and claims that inositol is superior to metformin for long-term weight maintenance. None of those figures trace to a named trial, author, or sample size in the pages that cite them, and several of the same sites sell the prescriptions or supplements they are comparing. The 2026 umbrella review's actual numbers, a 2.75 relative risk for ovulation and a 1.29 relative risk for pregnancy, are real signals, but they are not the same as 40 to 70% of women. An earlier 2024 review from the Natural Medicines database was more skeptical still, stating plainly that inositol "doesn't seem to increase the chance of getting pregnant" despite marketing claims to the contrary. The honest reading sits between those two: a real but modest, low-certainty effect, not a fertility guarantee.

Myo-inositol vs D-chiro-inositol, and the dose that actually got studied

The 2026 review found myo-inositol, taken alone or with folic acid, delivered the most consistent metabolic and reproductive benefits. D-chiro-inositol on its own rests on fewer and smaller trials, so the authors urged caution before treating it as equally proven. Combining both forms, despite being the most heavily marketed version, did not clearly outperform myo-inositol alone. Where a dose was specified, trials mostly used 2 to 4 grams of myo-inositol daily, sometimes with 400 micrograms of folic acid, for 12 weeks or longer. That is a meaningfully smaller and more specific protocol than the vague take-inositol-for-hormone-balance framing common in wellness content, which rarely names a form, ratio, or minimum duration. None of the trials in the review tested whether over-the-counter products actually deliver the labeled 40:1 ratio, which is a separate, unanswered question from whether the ratio works when it is accurate.

How it stacks up against metformin

Metformin is the more established option for insulin resistance in PCOS, so the comparison matters. The 2026 review found most outcomes, including fasting glucose and overall BMI, did not differ significantly between inositol and metformin. Inositol edged ahead on lower triglycerides and a higher pregnancy rate in some trials (RR 1.43), which is a genuine finding, not a sweeping claim that it beats metformin outright. For people who stop metformin due to gastrointestinal side effects, that can make inositol a reasonable supervised alternative. It is not evidence that inositol should replace metformin as a default first option, and nothing in the review tested inositol against newer insulin-sensitizing approaches.

Who PCOS actually affects, and who might benefit

A 2025 study reviewed by the CDC, drawing on electronic health records for 1.3 million US women aged 18 to 44, found a crude PCOS prevalence of 2.1%, rising to 6.7% among women with class 3 obesity. The same paper notes that global survey-based estimates run far higher, 10 to 13%, and that a large share of US cases likely go undiagnosed. That gap matters for this piece: most people searching for inositol and hormone balance are not seeking it for a diagnosed condition where the trial evidence applies. The review's benefits are specific to women diagnosed with PCOS, mostly those with insulin resistance or irregular ovulation, not a general audience hoping for vague hormonal improvement. If you're in that women's-health supplement lane already, our look at seed cycling covers a related hormone-balance trend with its own, separate evidence gap.

Cost, safety and what to watch for

Myo-inositol supplements typically run $15 to $30 for a month's supply at the studied 2 to 4 gram dose, cheaper than many branded metformin alternatives and most compounded hormone products. Side effects are mostly mild and dose-related: diarrhea, gas and nausea, more common above 4 grams a day. Long-term safety data beyond several months is limited, since most trials ran 12 to 24 weeks. Inositol supplements are not FDA-regulated for purity or dose accuracy the way a prescription drug is, so a product that claims the 40:1 ratio is not guaranteed to actually contain it, and third-party testing seals are worth checking before buying. Anyone on diabetes medication should talk to a clinician before adding inositol, since stacking insulin-sensitizing agents without monitoring is exactly the kind of unsupervised change that erodes any benefit. For a broader look at how we grade supplement claims in this space, see our evidence-first take on menopause supplements.

Our take

Inositol is one of the rare supplements where a real, peer-reviewed signal exists behind the hype, not just testimonials. But the signal is modest, graded low to very low quality overall, and specific to diagnosed PCOS, not general hormone balance. The dramatic percentage claims driving its current popularity do not hold up against the trial data. At 2 to 4 grams of myo-inositol daily, it is a low-risk option worth discussing with a clinician alongside, not instead of, established care.

This is general information, not medical advice. Talk to a clinician before changing anything, especially if you are pregnant, nursing, or managing a condition.